Prothena Corp. Plc (PRTA)
9.985
-0.38
(-3.62%)
USD |
NASDAQ |
Dec 15, 16:00
9.985
0.00 (0.00%)
After-Hours: 20:00
Prothena Free Cash Flow: -191.52M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alkermes Plc | 490.87M |
| Amarin Corp. Plc | -21.82M |
| Jazz Pharmaceuticals Plc | 1.282B |
| Iterum Therapeutics Plc | -19.62M |
| GH Research Plc | -42.32M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -43.17M |
| Cash from Investing (Quarterly) | -0.0114M |
| Cash from Financing (Quarterly) | -0.0187M |
| Free Cash Flow Per Share (Quarterly) | -0.8022 |
| Free Cash Flow to Equity (Quarterly) | -42.48M |
| Free Cash Flow to Firm (Quarterly) | -43.18M |
| Free Cash Flow Yield | -35.64% |